Deputy Director of Science US FOOD AND DRUG ADMINISTRATION Silver Spring, Maryland
This presentation will describe FDA experience in pharmaceutical manufacturing innovation, discuss technical and regulatory challenges related to development, implementation, and regulatory assessment of new technologies, and explain current FDA/CDER’s effort to address these challenges.
Learning Objectives:
Upon completion, participants will be able to learn about FDA's effort to modernize pharmaceutical development and manufacturing
Upon completion, participants will be able to learn about FDA's Emerging Technology Program
Upon completion, participants will be able to learn about FDA's effort to modernize policy in advanced manufacturing
